Research programme: allosteric modulators PROTACs - Beactica
Alternative Names: Allosteric modulators - BeacticaLatest Information Update: 19 Oct 2022
At a glance
- Originator Beactica
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 19 Oct 2022 Early research in Cancer in Sweden (unspecified route) (Beactica Pipeline; October 2022)